Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash
Immediately Accretive Combination Creates a Unique Global, Vertically Integrated Biosimilars Leader BENGALURU, India, Feb. 28, 2022 /PRNewswire/ — Biocon Biologics...
Source: fnarena.com